Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - Changes at Banyan Biomarkers:

This article was originally published in Clinica

Executive Summary

Ronald Hayes and Kevin Wang, two of the three founders of Banyan Biomarkers (Gainesville, Florida), have joined the firm on a full time basis. The company is developing point-of-care tests to diagnose brain injury. As director of innovative research and clinical programmes, Dr Hayes will manage clinical developments. Dr Wang is named as chief scientific officer and associate director of the research and clinical programmes. Both executives have been widely published, and both previously held senior executive and professorial positions at the University of Florida's traumatic brain injury studies centre.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048620

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel